AttributesValues
type
value
  • We are gratified to see the broad discussion of our manuscript, %22Use of SARS-CoV-2 infected deceased organ donors: Should we always 'just say no?'%22 and the companion manuscript by Shah et al., %22Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors.%221,2 Our viewpoint argues that the risk of SARS-CoV-2 transmission from asymptomatic or minimally symptomatic donors is likely very low. For selected patients with imminently life-threatening organ failure, transplants from deceased donors with asymptomatic or mild SARS-CoV-2 infection may offer a favorable risk/benefit balance, although factors beyond transmission risk must also be considered.
Subject
  • Zoonoses
  • Autoimmune diseases
  • COVID-19
  • Disulfiram-like drugs
  • Organ failure
  • Sarbecovirus
  • Chiroptera-borne diseases
  • Infraspecific virus taxa
part of
is abstract of
is hasSource of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software